Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP46797.RAP7YYz92uP1xmbpE04fNL28B9smHPjsUM2R_7ok3IqVg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP46797.RAP7YYz92uP1xmbpE04fNL28B9smHPjsUM2R_7ok3IqVg130_assertion type Assertion NP46797.RAP7YYz92uP1xmbpE04fNL28B9smHPjsUM2R_7ok3IqVg130_head.
- NP46797.RAP7YYz92uP1xmbpE04fNL28B9smHPjsUM2R_7ok3IqVg130_assertion description "[Rare inactivating mutations in BRCA1, BRCA2, ATM, TP53 and CHEK2 confer relative risks for breast cancer between about 2 and more than 10, but more common variants in these genes are generally considered of little or no clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP46797.RAP7YYz92uP1xmbpE04fNL28B9smHPjsUM2R_7ok3IqVg130_provenance.
- NP46797.RAP7YYz92uP1xmbpE04fNL28B9smHPjsUM2R_7ok3IqVg130_assertion evidence source_evidence_literature NP46797.RAP7YYz92uP1xmbpE04fNL28B9smHPjsUM2R_7ok3IqVg130_provenance.
- NP46797.RAP7YYz92uP1xmbpE04fNL28B9smHPjsUM2R_7ok3IqVg130_assertion SIO_000772 17341484 NP46797.RAP7YYz92uP1xmbpE04fNL28B9smHPjsUM2R_7ok3IqVg130_provenance.
- NP46797.RAP7YYz92uP1xmbpE04fNL28B9smHPjsUM2R_7ok3IqVg130_assertion wasDerivedFrom gad-20130706 NP46797.RAP7YYz92uP1xmbpE04fNL28B9smHPjsUM2R_7ok3IqVg130_provenance.
- NP46797.RAP7YYz92uP1xmbpE04fNL28B9smHPjsUM2R_7ok3IqVg130_assertion wasGeneratedBy ECO_0000203 NP46797.RAP7YYz92uP1xmbpE04fNL28B9smHPjsUM2R_7ok3IqVg130_provenance.